Global 
Deutschland Liver and Bile
Dig Liver Dis. 2022;54(4):509–14
Outcome of pregnancy in patients with primary sclerosing cholangitis
Background: Data on the clinical course of primary sclerosing cholangitis (PSC) during pregnancy remain scarce. Herein, the authors assessed the maternal and fetal outcomes of pregnancy in this condition.
Methods: They reviewed 104 consecutive female outpatients with PSC using a structured questionnaire. The outcomes were assessed both before and after the diagnosis of PSC.
Results: In total, 62 patients (60%) reported 126 pregnancies. Of these, 25 patients reported 44 pregnancies occurring after the diagnosis of PSC. There were 2 (5%) pregnancies in progress, and among the completed pregnancies there were 34 (80%) live births, 6 (14%) miscarriages, 1 (2%) stillbirth, and 1 (2%) termination. The median neonatal APGAR score was 10, the median body weight was 3375 g and the median body length was 55 cm. In 3 pregnancies, there was a flare-up of inflammatory bowel disease. In 45 patients, 82 pregnancies occurred before PSC was diagnosed with comparable maternal and fetal outcomes. Out of 42 pregnancies following PSC diagnosis, in 29 ursodeoxycholic acid (UDCA) was continued. There was no difference in the fetal outcomes between the UDCA and non-UDCA groups.
Conclusions: Pregnancy in patients with primary sclerosing cholangitis seems to be well tolerated, but should be closely monitored by an obstetrician and an experienced hepatologist.